MASH and Cardiometabolic Health: Pharmacotherapy and Emerging Therapies (Part 2)
Read on for pharmacotherapy, emerging treatments, & practical strategies for managing MASH in complex patients!
MASH and Cardiometabolic Health: Practical Treatments for Managing Complex Patients (Part 1)Â
Understand key treatment approaches for MASH to stay informed and deliver evidence-based care. Start reading now!
From NASH to MASH: New Terms for Liver Diseases Unveiled at the 2023 Cardiometabolic Health Congress
A session at the 18th Annual Cardiometabolic Health Congress (CMHC), explored the intersection of cardiometabolic conditions such as obesity and insulin resistance with liver disease, beginning with some important new updates on the preferred terms for these diseases. On Thursday, Oct. 19, 2023, attendees of the 18th Annual CMHC in Boston heard from experts […]
